Plant Based Investments
January 15, 2020 -- InvestorsHub NewsWire -- via CorporateAds.com -- Whether you believe they're more ethical, better for the environment, or just plain healthier, plant-based Foods and Beverages are taking over and it's hard to argue with the incredible stock price action we're seeing. CBD in food and snacks cannot be ignored anymore, it helps and people are buying. Here is why:
Beyond Meat (Stock Symbol: BYND) the buzzy plant-based meat alternative startup that captured attention with its blockbuster IPO in 2019, notched its best weekly performance in seven months.
BYND been backed by a long list of investors, including Bill Gates, Twitter co-founders Biz Stone and Evan Williams, the meat company Tyson Foods, the Humane Society and Leonardo DiCaprio.
Shares of the company have gained about 27% over the past five days, their best weekly gain since July. The S&P 500 has gained roughly 1% over the same timeframe.
There have been a number of stock-moving events that have lifted Beyond Meat this week. On Tuesday, Reuters reported that its main rival in the plant-based meat space, Impossible Foods, was abandoning attempts to land a deal to supply McDonald's with burgers. Speaking of Plants, well….
American Premium Water Corporation (OTC: HIPH) is a CBD infused beverage and cosmetic company with premium consumer products focused on businesses in the health, beauty and biotech sectors. The company is focused on harnessing the powers of Nano technologies paired without cannabidiol (CBD) to treat health disorders and enhance quality of life. HIPH's portfolio includes the LALPINA Hydro and LALPINA CBD brands (www.lalpinahydrocbd.com), Gents (www.gentsco.com), Vanexxe (www.vanexxe.com) and plant + body essentials (www.plantbodyessentials.com).
The plant + body essentials brand is priced competitively with comparable products. The CBD topicals segment of the market is attractive, as big box retailers have embraced this product category. This a growing segment of the market that has no clear market front runners; there is a significant potential for HIPH to capture market share in this category. As big box retailers have had some hesitation carrying CBD-infused ingestibles because of the lack of clarity from the FDA, cosmetics have been more widely accepted, as CVS, Walgreens, Krogers, and other large chains have begun to stock CBD topical products. HIPH is well positioned to excel in these chains.
Nightfood Sleep-Friendly Ice Cream (OTCQB: NGTF), is Solving America's $50 Billion-Dollar Nighttime Snacking Problem
- Formulated by Sleep Experts as a Better, Healthier Nighttime Snack, With Less Fat, Less Sugar, and Fewer Calories
- Nightfood Brand Won The 2019 Product of the Year Award
- New Top-10 Supermarket Chain Picking up Nightfood Line in February
- Nationwide Supermarket and Hotel Rollout Underway
In the United States, nighttime snacking has become an unhealthy epidemic. For millions, ice cream is their #1 nighttime snack choice. Nightfood (OTC: NGTF) offers a delicious and sleep-friendly ice cream developed by sleep and nutrition experts, offering of the Year award in the ice cream category in a Kantar survey of over 40,000 consumers and the 2019 World Dairy Innovation Award as Best New Ice Cream.
- New Distribution Commitment From Top-10 Supermarket Chain
On November 20th, NGTF announced that Nightfood ice cream would soon be made available in a large division of one of the nation's top-10 supermarket chains. The new chain will be taking on seven flavors of Nightfood, including Full Moon Vanilla, Midnight Chocolate, Cherry Eclipse (cherry ice cream with chocolate chips and cherry pieces), Milk & Cookie Dough, After Dinner Mint Chip, Cookies n' Dreams, and Bed and Breakfast (maple ice cream with waffle pieces).
- Nightfood Ice Cream NOW available in the Harris Teeter Supermarket Chain
After manufacturing their first pint in early 2019, Nightfood (NGTF) ice cream is quickly establishing a national footprint. On October 8th, it was announced that Harris Teeter, a 260-store division of Kroger, was also adding a full shelf of Nightfood ice cream. With locations throughout North and South Carolina, plus Virginia, Maryland, and the Washington DC area, this Kroger division is Nightfood's largest distribution partner to date.
For more information on this innovative company visit: https://nightfood.com/
CV Sciences, Inc. (OTC: CVSI)
CV Sciences, Inc. (CVSI) operates two distinct business segments: a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors; and a drug development division focused on developing and commercializing CBD-based novel therapeutics utilizing CBD. The Company's PlusCBD™ Oil products are sold at more than 5,500 retail locations throughout the U.S. and it is the top-selling brand of hemp-derived CBD on the market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences' state-of-the-art facility follows all guidelines for Good Manufacturing Practices (GMP) and the Company's full spectrum hemp extracts are processed, produced, and tested throughout the manufacturing process to confirm the cannabinoid content meets strict company standards. With a commitment to science, PlusCBD™ Oil's benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. PlusCBD™ Oil was the first hemp CBD supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. CV Sciences, Inc. has primary offices and facilities in San Diego, California. Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.
DISCLAIMER: CorporateAds.com (CA) is a third-party publisher and news dissemination service provider. CA is NOT affiliated in any manner with any company mentioned herein. CA is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. CA's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. CA is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. CA has been compensated $800.00 for this release and HOLDS NO SHARES OF (NASDAQ:BYND), (NYSE:MCD), (OTC:NGTF), (NYSE:KR), (NYSE:CVS), (OTC:HIPH), (OTC:CVSI) or ANY COMPANY NAMED IN THIS RELEASE.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.